润都股份(002923.SZ)：布洛芬片获得药品注册证书

Core Viewpoint - Rundu Co., Ltd. has received a drug registration certificate for Ibuprofen tablets from the National Medical Products Administration, indicating a significant regulatory approval for the company’s product line [1] Group 1: Company Information - Rundu Co., Ltd. (002923.SZ) has announced the receipt of a drug registration certificate for Ibuprofen tablets [1] - The Ibuprofen tablets are indicated for the relief of mild to moderate pain, including headaches, joint pain, migraines, toothaches, muscle pain, neuralgia, and dysmenorrhea [1] - The product is also used to reduce fever caused by common colds or influenza [1]